U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879353) titled 'Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery' on March 11.
Brief Summary: This study evaluated the effectiveness of a single dose of tranexamic acid compared to a placebo in reducing blood loss and the need for blood transfusions in women undergoing surgery for ovarian cancer. Tranexamic acid, a medication that helps control bleeding by stabilizing blood clots, has been widely used in other surgical settings but has not been well studied in ovarian cancer surgery.
Participants were randomly assigned to receive either a single dose of tranexamic acid or a placebo before surgery. Blood loss was mea...